BioCompute Object: Difference between revisions

Revision as of 15:58, 28 November 2023

Revision as of 15:59, 28 November 2023

Line 45:

* DNAnexus and PrecisionFDA facilitate the generation of BCOs by importing workflows, allowing users to edit descriptive content. The platform supports metadata import and export of WDL and CWL scripts, and offers the BCOnexus tool, which is a high-level, platform-free tool with a graphical user interface, and which lets a user merge BCOs.

* Velsera's Seven Bridges Genomics and Cancer Genomics Cloud also have support for BioCompute by enabling direct pre-population of BCO fields from workflows.

* BioCompute has also been integrated into [https://hivelab.biochemistry.gwu.edu/ HIVE] and the main Galaxy instance, both of which similarly enable users to automatically generate BCOs and edit content within these platforms. Integration into platforms is meant to improve data handling and collaboration, and graphical representations of BCOs are often more intuitive ways of browsing or reading BCOs.

* BioCompute has also been implemented in the Common Fund Data Elements Playbook Partnership project. This implementation lets a user save a workflow when they're happy with the results, which aids in traceability through the network of independently-versioned resources, allowing users to save queries and annotate them for future use, sharing, or repeatability, aligning with its role in advancing bioinformatics practices.

Integration into platforms is meant to improve data handling and collaboration, and graphical representations of BCOs are often more intuitive ways of browsing or reading BCOs.

== References ==